Genetic prodrug activation therapy for pancreatic cancer.
Rigg
A S
AS
Imperial Cancer Research Fund Molecular Oncology Unit, Hammersmith Hospital, Imperial College School of Medicine, London, UK.
Lemoine
N R
NR
D000230:Adenocarcinoma / Q000188:drug therapy*; D000818:Animals; D001711:Biotransformation; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D011355:Prodrugs / Q000378:metabolism / Q000627:therapeutic use*
D011355:Prodrugs